Abstract

We synthesized spinel ferrite nanoensembles (MnFe2O4, CoFe2O4, and Fe3O4) using the chemical co-precipitation method and characterized their physical, chemical, and magnetic properties by X-ray diffraction (XRD), transmission electron microscopy (TEM), physical properties measurement system (PPMS), Mössbauer spectroscopy, Fourier transform infrared spectroscopy (FTIR), dynamic light scattering (DLS) and Raman spectroscopy. Their relaxation properties and potential for hyperthermia therapy were determined using nuclear magnetic resonance (NMR) and cell viability assay, respectively. XRD and TEM data confirmed that the particle core sizes were 6–9 nm before coating while their sizes increased to 10–14 nm and 14–20 nm after coating with chitosan and polyethylene glycol (PEG), respectively. Mössbauer spectroscopy showed superparamagnetic behavior for MnFe2O4 nanoparticles and ferrimagnetic behavior for the CoFe2O4 and Fe3O4 nanoparticles. A detailed studies of MH loops of all three ferrites before and after coating showed surface functionalization by a large reduction of coercivity and anisotropy. The successful coating was further confirmed by the peak shifts in the FTIR spectra of the particles whereas Raman spectra of coated ferrites also displayed the characteristic absorption patterns and suppression of the ferrite peaks suggesting successful coating. The induced heating profile of the nanoparticles in stable suspension was tested with a radio frequency magnetic field of 76 mT and a frequency of 400 kHz. High mortality (>98%) of 9 L gliosarcoma cancer cells by hyperthermia suggested that these nanoparticles could be used for cancer therapy. Transverse relaxivities (r2) determined by NMR for chitosan-coated MnFe2O4, CoFe2O4, and Fe3O4 nanoparticles were 297 (±22), 353 (±26), and 345 (±13), mM−1S−1, while for PEG-coated nanoparticles are 165 (±22), 146 (±14), and 159 (±07) mM−1S−1, respectively. Overall these spinel ferrite nanoensembles show great promise for cancer theranostics research applications.

Highlights

  • IntroductionThe nano ferrite-based contrast agents for biomedicine applications were extensively studied and these can transform both cancer diagnostics and therapeutics (Jordan et al, 1997; Fortin et al, 2007; Prasad et al, 2007; Zhou et al, 2007; Dobson 2008; Gazeau et al, 2008; McCArthy and Weissleder 2008; Lu et al, 2009; Tong et al, 2010; Tsai et al, 2010; Lee et al, 2011; Rümenapp et al, 2012; Pinter et al, 2016; Nguyen et al, 2018)

  • When exposed to an alternating magnetic field local temperature can be increased because higher magnetic moments coupled with controlled anisotropy of nano ferrites give rise to enhanced specific loss power (SLP) for induced heating

  • The lattice parameters determined from the x-ray diffraction data using the Nelson-Riley method were 8.49, 8.33, and 8.20 Å for MnFe2O4, CoFe2O4, and Fe3O4 nanoparticles, respectively

Read more

Summary

Introduction

The nano ferrite-based contrast agents for biomedicine applications were extensively studied and these can transform both cancer diagnostics and therapeutics (Jordan et al, 1997; Fortin et al, 2007; Prasad et al, 2007; Zhou et al, 2007; Dobson 2008; Gazeau et al, 2008; McCArthy and Weissleder 2008; Lu et al, 2009; Tong et al, 2010; Tsai et al, 2010; Lee et al, 2011; Rümenapp et al, 2012; Pinter et al, 2016; Nguyen et al, 2018). Transverse relaxation time (T2) of these particles decreases with their increasing magnetic moment. A higher magnetic moment of nano-ensembles shortens relaxation time, which reduces the number of particles needed for an efficient contrast enhancement. When exposed to an alternating magnetic field local temperature can be increased (i.e., hyperthermia) because higher magnetic moments coupled with controlled anisotropy of nano ferrites give rise to enhanced specific loss power (SLP) for induced heating. To enhance the potential of these ferrites in MRI contrast and thermal therapeutic applications, these nano ferrite-based contrast agents have to overcome the toxicity issues by applying surface coating (polymer, polysaccharide) and/or encapsulation (e.g., in lipids). The coating improves the injectability, biocompatibility, and may be exploited to achieve tissue-targeting (Sharifi et al, 2012; Issa et al, 2013)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call